Cargando…
Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy
With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542336/ https://www.ncbi.nlm.nih.gov/pubmed/34688292 http://dx.doi.org/10.1186/s12951-021-01066-1 |
_version_ | 1784589409633435648 |
---|---|
author | Zhong, Yuanyuan Zhang, Li Sun, Shian Zhou, Zhenghao Ma, Yunsu Hong, Hao Yang, Dongzhi |
author_facet | Zhong, Yuanyuan Zhang, Li Sun, Shian Zhou, Zhenghao Ma, Yunsu Hong, Hao Yang, Dongzhi |
author_sort | Zhong, Yuanyuan |
collection | PubMed |
description | With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The anti-angiogenic drug, CA4P was initially released due to the degradation of Gel, followed by the anti-cell proliferative drug, DOX, released from hMSN in tumor microenvironment. Results showed that CA4P was mainly released at the early stage. At 48 h, CA4P release reached 71.08%, while DOX was only 24.39%. At 144 h, CA4P was 78.20%, while DOX release significantly increased to 61.60%, showing an obvious sequential release behavior. Photodynamic properties of porphyrin endow hydrogel (ϕ(Δ(Gel)) = 0.91) with enhanced tumor therapy effect. In vitro and in vivo experiments showed that dual drugs treated groups have better tumor inhibition than solo drug under near infrared laser irradiation, indicating the effectivity of combined photodynamic-chemotherapy. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01066-1. |
format | Online Article Text |
id | pubmed-8542336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-85423362021-10-25 Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy Zhong, Yuanyuan Zhang, Li Sun, Shian Zhou, Zhenghao Ma, Yunsu Hong, Hao Yang, Dongzhi J Nanobiotechnology Research With hollow mesoporous silica (hMSN) and injectable macroporous hydrogel (Gel) used as the internal and external drug-loading material respectively, a sequential drug delivery system DOX-CA4P@Gel was constructed, in which combretastatin A4 phosphate (CA4P) and doxorubicin (DOX) were both loaded. The anti-angiogenic drug, CA4P was initially released due to the degradation of Gel, followed by the anti-cell proliferative drug, DOX, released from hMSN in tumor microenvironment. Results showed that CA4P was mainly released at the early stage. At 48 h, CA4P release reached 71.08%, while DOX was only 24.39%. At 144 h, CA4P was 78.20%, while DOX release significantly increased to 61.60%, showing an obvious sequential release behavior. Photodynamic properties of porphyrin endow hydrogel (ϕ(Δ(Gel)) = 0.91) with enhanced tumor therapy effect. In vitro and in vivo experiments showed that dual drugs treated groups have better tumor inhibition than solo drug under near infrared laser irradiation, indicating the effectivity of combined photodynamic-chemotherapy. [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-021-01066-1. BioMed Central 2021-10-23 /pmc/articles/PMC8542336/ /pubmed/34688292 http://dx.doi.org/10.1186/s12951-021-01066-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Zhong, Yuanyuan Zhang, Li Sun, Shian Zhou, Zhenghao Ma, Yunsu Hong, Hao Yang, Dongzhi Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title | Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title_full | Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title_fullStr | Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title_full_unstemmed | Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title_short | Sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
title_sort | sequential drug delivery by injectable macroporous hydrogels for combined photodynamic-chemotherapy |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542336/ https://www.ncbi.nlm.nih.gov/pubmed/34688292 http://dx.doi.org/10.1186/s12951-021-01066-1 |
work_keys_str_mv | AT zhongyuanyuan sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT zhangli sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT sunshian sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT zhouzhenghao sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT mayunsu sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT honghao sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy AT yangdongzhi sequentialdrugdeliverybyinjectablemacroporoushydrogelsforcombinedphotodynamicchemotherapy |